From Brigham and Women's Hospital, Ariadne Labs, Harvard T.H. Chan School of Public Health, and Harvard Medical School, Boston, Massachusetts; CVS Health, Woonsocket, Rhode Island; and Aetna, Hartford, Connecticut.
Ann Intern Med. 2017 Jan 17;166(2):81-88. doi: 10.7326/M15-2659. Epub 2016 Nov 15.
Despite the widespread adoption of patient-centered medical homes into primary care practice, the evidence supporting their effect on health care outcomes has come primarily from geographically localized and well-integrated health systems.
To assess the association between medication adherence and medical homes in a national patient and provider population, given the strong ties between adherence to chronic disease medications and health care quality and spending.
Retrospective cohort study.
Claims from a large national health insurer.
Patients initiating therapy with common medications for chronic diseases (diabetes, hypertension, and hyperlipidemia) between 2011 and 2013.
Medication adherence in the 12 months after treatment initiation was compared among patients cared for by providers practicing in National Committee for Quality Assurance-recognized patient-centered medical homes and propensity score-matched control practices in the same Primary Care Service Areas. Linear mixed models were used to examine the association between medical homes and adherence.
Of 313 765 patients meeting study criteria, 18 611 (5.9%) received care in patient-centered medical homes. Mean rates of adherence were 64% among medical home patients and 59% among control patients. Among 4660 matched control and medical home practices, medication adherence was significantly higher in medical homes (2.2% [95% CI, 1.5% to 2.9%]). The association between medical homes and better adherence did not differ significantly by disease state (diabetes, 3.0% [CI, 1.5% to 4.6%]; hypertension, 3.2% [CI, 2.2% to 4.2%]; hyperlipidemia, 1.5% [CI, 0.6% to 2.5%]).
Clinical outcomes related to medication adherence were not assessed.
Receipt of care in a patient-centered medical home is associated with better adherence, a vital measure of health care quality, among patients initiating treatment with medications for common high-cost chronic diseases.
CVS Health.
尽管以患者为中心的医疗之家已广泛应用于初级保健实践,但支持其对医疗保健结果影响的证据主要来自地理位置上局部且整合良好的卫生系统。
鉴于慢性病药物治疗依从性与医疗质量和支出之间存在紧密联系,在全国范围内的患者和医疗服务提供者人群中,评估药物治疗依从性与医疗之家之间的关联。
回顾性队列研究。
来自一家大型全国性健康保险公司的理赔数据。
2011 年至 2013 年间接受常见慢性病(糖尿病、高血压和高血脂)治疗的患者。
在治疗开始后的 12 个月内,比较接受经美国国家质量保证委员会认可的以患者为中心的医疗之家的提供者治疗的患者和同一基层医疗服务区域中经倾向评分匹配的对照实践的患者之间的药物治疗依从性。使用线性混合模型来检验医疗之家与依从性之间的关联。
在符合研究标准的 313765 名患者中,有 18611 名(5.9%)接受了以患者为中心的医疗之家的治疗。医疗之家患者的药物治疗依从率为 64%,对照组患者为 59%。在 4660 对匹配的对照和医疗之家实践中,医疗之家的药物治疗依从率显著更高(2.2%[95%CI,1.5%2.9%])。医疗之家与更好的依从性之间的关联在疾病状态方面没有显著差异(糖尿病,3.0%[CI,1.5%4.6%];高血压,3.2%[CI,2.2%4.2%];高血脂,1.5%[CI,0.6%2.5%])。
未评估与药物治疗依从性相关的临床结局。
在接受常见高成本慢性病药物治疗的患者中,接受以患者为中心的医疗之家的治疗与更好的依从性相关,这是医疗质量的重要衡量标准。
CVS 健康公司。